Swedish Orphan Biovitrum AB (publ)
Swedish Orphan Biovitrum AB (publ) (BIOVF) Revenue
Annual & quarterly revenue history · segment & region breakdown
BIOVF · revenue · updated Jun 10, 2026
Core revenue metrics
Trailing 12 monthsSwedish Orphan Biovitrum AB (publ) trailing twelve-month (TTM) revenue is $28.88B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
Compare revenue vs peers
Drug Manufacturers - Specialty & GenericCompare BIOVF revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Swedish Orphan Biovitrum AB (publ) receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Swedish Orphan Biovitrum AB (publ) reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Swedish Orphan Biovitrum AB (publ)'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
BIOVF revenue · 4 questionsBIOVF's trailing twelve-month (TTM) revenue is $28.88B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Swedish Orphan Biovitrum AB (publ) SEC filings · GAAP · Swedish Orphan Biovitrum AB (publ) SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026